Their monitoring to identify possible episodes of early myocardial ischemia by dosing new markers that have proven their usefulness such as Cx43, JunB, and TUNEL assays could represent a turning point in the prevention of SCD [55]. This evidence concerns the gene GJA1 and Schnyder corneal dystrophy.